{"References": [{"title": "Phosphodiesterase 5 inhibitors: current status and potential applications", "authors": "Hossein A. Ghofrani, Friedrich Grimminger", "journal": "Nature Reviews Drug Discovery", "year": "2003", "volumes": "2", "first page": "674", "last page": "684", "DOI": "10.1038/nrd1175"}, {"title": "The role of phosphodiesterase 5 inhibitors in cardioprotection", "authors": "Rakesh C. Kukreja, Fadi N. Salloum, Amadou K. S. Camara", "journal": "Frontiers in Bioscience", "year": "2009", "volumes": "14", "first page": "4714", "last page": "4724", "DOI": "10.2741/3560"}, {"title": "Phosphodiesterase 5 inhibitors and endothelial function in patients with metabolic syndrome", "authors": "Carmine Gazzaruso, Andrea Giustina", "journal": "Journal of Endocrinological Investigation", "year": "2011", "volumes": "34", "first page": "e1", "last page": "e7", "DOI": "10.3275/7247"}, {"title": "Phosphodiesterase 5 inhibitors: novel therapeutic applications", "authors": "George J. Christ, Karl-Erik Andersson", "journal": "Nature Reviews Urology", "year": "2013", "volumes": "10", "first page": "513", "last page": "525", "DOI": "10.1038/nrurol.2013.143"}, {"title": "Therapeutic potential of phosphodiesterase 5 inhibitors for cardiovascular disease", "authors": "David A. Kass, Joseph A. Hill", "journal": "Circulation", "year": "2007", "volumes": "116", "first page": "2390", "last page": "2401", "DOI": "10.1161/CIRCULATIONAHA.107.690677"}, {"title": "Phosphodiesterase 5 inhibitors in the treatment of erectile dysfunction and beyond", "authors": "Arthur L. Burnett, Trinity J. Bivalacqua", "journal": "Nature Reviews Urology", "year": "2011", "volumes": "8", "first page": "417", "last page": "427", "DOI": "10.1038/nrurol.2011.85"}, {"title": "Phosphodiesterase 5 inhibitors and their potential for treating metabolic syndrome", "authors": "Michael A. Weber, George L. Bakris", "journal": "Journal of Clinical Hypertension", "year": "2008", "volumes": "10", "first page": "50", "last page": "56", "DOI": "10.1111/j.1751-7176.2007.07523.x"}, {"title": "The role of phosphodiesterase 5 inhibitors in aging and age-related diseases", "authors": "Jeremy P. E. Spencer, David Vauzour", "journal": "Ageing Research Reviews", "year": "2012", "volumes": "11", "first page": "485", "last page": "498", "DOI": "10.1016/j.arr.2012.03.003"}, {"title": "Phosphodiesterase 5 inhibitors and cancer: a review of the current evidence", "authors": "Robert H. Weiss, Michael R. Freeman", "journal": "Cancer Research", "year": "2010", "volumes": "70", "first page": "775", "last page": "783", "DOI": "10.1158/0008-5472.CAN-09-3169"}, {"title": "Endothelial dysfunction and phosphodiesterase 5 inhibitors in the treatment of cardiovascular disease", "authors": "Julio A. Panza, Arshed A. Quyyumi", "journal": "Journal of the American College of Cardiology", "year": "2006", "volumes": "47", "first page": "S1", "last page": "S8", "DOI": "10.1016/j.jacc.2005.12.001"}]}